Pacira Biosciences Inc (OQ:PCRX)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Pfizer (N:PFE)
Odonate Therapeutics (OQ:ODT)
Latest 10 SEC filings (by transaction date) for PCRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -9,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 9,000 $5.49
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000 $1.61
Jun 12/19 Jun 10/19 Riker Lauren Bullaro Direct Ownership Common Stock S - Open market or private sale -2,126 $44.28
Jun 6/19 Jun 5/19 Winston Roy Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 33,800  
Jun 6/19 Jun 5/19 Winston Roy Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,600  
Jun 6/19 Jun 5/19 Williams Kristen Marie Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 33,800  
Jun 6/19 Jun 5/19 Williams Kristen Marie Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,600  
Jun 6/19 Jun 5/19 Stack David M Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 142,100  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PCRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -9,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 9,000 $5.49
Jun 13/19 Jun 11/19 Stack David M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000 $1.61
Jun 12/19 Jun 10/19 Riker Lauren Bullaro Direct Ownership Common Stock S - Open market or private sale -2,126 $44.28
Jun 6/19 Jun 5/19 Winston Roy Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 33,800  
Jun 6/19 Jun 5/19 Winston Roy Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,600  
Jun 6/19 Jun 4/19 Winston Roy Direct Ownership Common Stock S - Open market or private sale -722 $42.91
Jun 6/19 Jun 5/19 Williams Kristen Marie Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 33,800  
Jun 6/19 Jun 5/19 Williams Kristen Marie Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,600  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $PCRX

StockTwits